B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ly 3009120

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ly 3009120, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bafetinib
10 shared targets
naporafenib
3 shared targets
dabrafenib
10 shared targets
cep
8 shared targets
dasatinib
7 shared targets
regorafenib
7 shared targets
golvatinib
8 shared targets
avutometinib
3 shared targets
ponatinib
12 shared targets
Vemurafenib
7 shared targets · score 43.2
Loading evidence profile...

This evidence profile for Ly 3009120 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.